Clinical Trials · NCT03048578
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- NYU Langone Health
- Enrollment
- 132
- Start date
- May 2017
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of Participants Losing at Least 5% Enrollment Body Weight Measured Using Cochran-Mantel-Haenszel (CMH) Test